Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Copur, Mehmet S. [1 ]
Gauchan, Dron [1 ]
Crockett, David [1 ]
机构：
[1] Catholic Hlth Initiat, St Francis Canc Treatment Ctr, Grand Isl, NE 68803 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 22期
关键词：
CHLORAMBUCIL; TRIALS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2142 / +
页数：2
相关论文
共 50 条
  • [21] Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
    Handunnetti, Sasanka
    Anderson, Mary Ann
    Roberts, Andrew W.
    Davids, Matthew S.
    Ma, Shuo
    Boyer, Michelle
    Arzt, Jennifer
    Al Masud, Abdullah
    Popovic, Relja
    Jacobson, Amanda
    Kim, Su Y.
    Seymour, John F.
    EJHAEM, 2021, 2 (02): : 266 - 271
  • [22] Rituximab for chronic lymphocytic leukemia
    Robak, Tadeusz
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (04) : 503 - 515
  • [23] Rituximab in chronic lymphocytic leukemia
    Danelle F. James
    Thomas J. Kipps
    Advances in Therapy, 2011, 28 : 534 - 554
  • [24] Rituximab in chronic lymphocytic leukemia
    Montserrat, E
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 34 - 39
  • [25] Rituximab in chronic lymphocytic leukemia
    James, Danelle F.
    Kipps, Thomas J.
    ADVANCES IN THERAPY, 2011, 28 (07) : 534 - 554
  • [26] Rituximab in Chronic Lymphocytic Leukemia
    Jaglowski, Samantha M.
    Byrd, John C.
    SEMINARS IN HEMATOLOGY, 2010, 47 (02) : 156 - 169
  • [27] Detailed Safety Analysis of Venetoclax Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
    Brander, Danielle M.
    Choi, Michael Y.
    Roberts, Andrew W.
    Ma, Shuo
    Lash, L. Leanne
    Verdugo, Maria
    Zhu, Ming
    Kim, Su Young
    Seymour, John F.
    BLOOD, 2016, 128 (22)
  • [28] Venetoclax for the treatment of patients with chronic lymphocytic leukemia
    Crombie, Jennifer
    Davids, Matthew S.
    FUTURE ONCOLOGY, 2017, 13 (14) : 1223 - 1232
  • [29] An update on the efficacy of Venetoclax for chronic lymphocytic leukemia
    Lovell, Alexandra R.
    Sawyers, Jacki
    Bose, Prithviraj
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (11) : 1307 - 1316
  • [30] Venetoclax Approved for Use in Chronic Lymphocytic Leukemia
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (05) : 339 - 339
12345